[1]
Siddiqi, T.J. et al. 2023. SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials. Global Cardiology. 1, 1 (Nov. 2023). DOI:https://doi.org/10.4081/cardio.2023.2.